Description
CLAVULIN is an antibiotic agent with a notably broad spectrum of activity against the
commonly occurring bacterial pathogens in general practice and hospital. The beta
lactamase inhibitory action of clavulanate extends the spectrum of amoxicillin to embrace
a wider range of organisms, including many resistant to other beta–lactam antibiotics.
CLAVULIN should be used in accordance with local official antibiotic–prescribing
guidelines and local susceptibility data.
CLAVULIN oral presentations for twice daily dosing, are indicated for short–term
treatment of bacterial infections at the following sites:
Upper respiratory tract infections (including ENT) e.g. tonsillitis, sinusitis, otitis media.
Lower respiratory tract infections e.g. acute exacerbation of chronic bronchitis, lobar and
bronchopneumonia.
Genito–urinary tract infections e.g. cystitis, urethritis, pyelonephritis.
Skin and soft tissue infections, e.g. boils, abscesses, cellulitis, wound infections.
Bone and joint infections e.g. osteomyelitis.
Dental infections e.g. dentoalveolar abscess
